ADRB2 and asthma: The FDA-approved drug, formoterol, is a long-lasting selective β2-adrenergic receptor (ADRB2) agonist that works as a bronchodilator and is prescribed as an inhalant for use in patients with chronic obstructive pulmonary disease and severe asthma [29, 30].